Sambavy Nadaraja

4PUBLICATIONS

8CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer genetics

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Sep 09, 2026

18F-FDG PET/CT-visualised immune-related hepatitis after immune checkpoint inhibitor combination treatment in a patient with metastatic melanoma.

|Jan 10, 2026

The Prognostic Value of Biomarkers Identified by [18F]FDG-PET/CT in Patients with High-Risk Melanoma Treated with Adjuvant Immunotherapy.

Anne-Line Mayland Madsen, Oke Gerke, Christina H Ruhlmann

|Sep 04, 2019

ARAP1 is an independent prognostic biomarker in older women with ovarian high-grade serous adenocarcinoma receiving first-line platinum-based antineoplastic therapy.

Sambavy Nadaraja, Doris Schledermann, Jørn Herrstedt

|Nov 22, 2018

Impact of Age, Comorbidity, and FIGO Stage on Treatment Choice and Mortality in Older Danish Patients with Gynecological Cancer: A Retrospective Register-Based Cohort Study.

Sambavy Nadaraja, Trine Lembrecht Jørgensen, Lars-Erik Matzen

Pageof 1

Frequent Collaborators

1 joint publications

Lars-Erik Matzen

1 joint publications

Jørn Herrstedt

1 joint publications

Henrik J Ditzel

1 joint publications

Anne-Line Mayland Madsen

1 joint publications

Oke Gerke

1 joint publications

Christina H Ruhlmann

1 joint publications

Malene Grubbe Hildebrandt

1 joint publications

Matthias Ploug Sejrsen

Frequent Collaborators

1 joint publications

Lars-Erik Matzen

1 joint publications

Jørn Herrstedt

1 joint publications

Henrik J Ditzel

1 joint publications

Anne-Line Mayland Madsen